Showing promise in the field of obesity therapy, retatrutide is a unique method. Different from many available medications, retatrutide works as a double agonist, at once targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) receptors. The simultaneous stimulation promotes multiple helpful effects, like e